Clinical Trials Browser

Phase 4 × OTHER × DMAC2L protein, human × Clear all

NCT06640738 2024-10-15

Investigating the Optimal Remifentanil and Dexmedetomidine Concentration for Uterine Fibroid Ablation

Phase 4 Not yet recruiting

Leiomyoma